Florida Attorney General Subpoenas CVS Pharmacy Over Alleged Anticompetitive Practices
Negative for
Florida's Attorney General has subpoenaed CVS Pharmacy as part of an investigation into alleged anticompetitive pharmacy practices, adding to a growing wave of state-level regulatory scrutiny targeting pharmacy benefit managers and large retail pharmacy chains.
Florida Joins the Regulatory Pile-On
CVS Health received a subpoena from the Florida Attorney General as part of an investigation into alleged anticompetitive practices by CVS Pharmacy. The subpoena follows a broader launched probe and is part of a national trend of state attorneys general examining the conduct of pharmacy benefit managers and large integrated pharmacy operators.
CVS Health operates across three interconnected businesses: CVS Pharmacy (retail), CVS Caremark (PBM), and Aetna (insurance). Critics have argued that this vertical integration creates structural conflicts of interest, with the PBM arm favouring drugs and formulary arrangements that benefit CVS Pharmacy's dispensing volumes at the expense of lower-cost alternatives for patients and payers.
PBM Scrutiny Is Accelerating
The CVS investigation sits within a broader regulatory wave targeting PBMs at both the federal and state level. The Federal Trade Commission released a critical report on PBM pricing practices in 2024, and multiple states have since introduced or enacted legislation requiring greater PBM transparency. Tennessee passed a new PBM law that major PBMs, including CVS Caremark, have challenged in court. The political climate around drug pricing, amplified by ongoing Congressional debates, has made PBM practices a high-profile target.
Separate Headwinds and Tailwinds
CVS is simultaneously navigating the regulatory pressure with several positive operational developments. The company has expanded its GLP-1 drug support programme, recognising the massive patient demand for obesity and diabetes medications and positioning CVS Specialty as a preferred access point. CVS also launched an internal AI learning academy, signalling investment in workforce reskilling. These operational initiatives are distinct from the legal risk, which relates to structural conduct concerns rather than product or service quality.
Sources
Frequently asked questions
What is a pharmacy benefit manager (PBM)?
A PBM is an intermediary that manages prescription drug benefits on behalf of health insurers and employers. PBMs negotiate prices with drug manufacturers, build formularies, and process claims. CVS Caremark is one of the three largest PBMs in the US.
What are the alleged anticompetitive practices?
State and federal investigations have focused on whether large integrated pharmacy operators like CVS use their PBM market power to steer patients toward their own retail pharmacies, disadvantage independent pharmacies, and limit transparency in drug pricing arrangements.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
One story is a data point. The pattern is the edge.
Reading one story at a time, you miss how the news adds up. Track CVS free and TradeTidings rolls every future headline into one clear positive, neutral or negative read, and alerts you the moment it turns.